Početna › Prekomjerna tjelesna masa › Minnesota
Kliničke studije za Prekomjerna tjelesna masa u državi Minnesota
13 studija za Prekomjerna tjelesna masa traži sudionike na lokacijama u državi Minnesota.
Gradovi u državi Minnesota
Službeni tekst studije (engleski)
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- University of Minnesota, Minneapolis
- Synexus Clinical Research US-MN, Richfield
U tijeku regrutacijaFaza 3
Od 8 do 18 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07253285A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Headlands Research - Twin Cities, Maplewood
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07823608A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Headlands Research-Twin Cities, Maplewood
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07794579A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Minnesota Masonic Children's Hospital, Minneapolis
- Mayo Clinic - PIN, Rochester
- Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
U tijeku regrutacijaFaza 3
Od 6 do 17 godina · Oba spola · Ažurirano 24. ruj 2026. · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Headlands Research-Twin Cities, Maplewood
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- Minneapolis Heart Institute Foundation, Minneapolis
U tijeku regrutacijaFaza 3
Od 45 do 99 godina · Oba spola · Ažurirano 22. ruj 2026. · NCT07037433A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Mankato
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- International Diabetes Center At Park Nicollet, Minneapolis
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Mankato
- ACCOMPLISH-2 Research Site, Minneapolis
U tijeku regrutacijaFaza 3Zdravi dobrovoljci dobrodošli
Od 18 do 79 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07654374Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Mankato
- ACCOMPLISH-1 Research Site, Richfield
U tijeku regrutacijaFaza 3
Od 18 do 79 godina · Oba spola · Ažurirano 10. kol 2026. · NCT07654361A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Clinical Research Institute of Minnesota, Minneapolis
U tijeku regrutacijaFaza 4
Od 18 do 65 godina · Oba spola · Ažurirano 27. srp 2026. · NCT07728383Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Minneapolis VA Health Care System, Minneapolis
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT06390345Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.